Oncology - Bone and Sarcomas

Meta-analysis: Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases

20 Jan, 2021 | 01:09h | UTC

Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis – Cochrane Library

 

---